← All organizations

Cyclerion Therapeutics, Inc.

For profitWebsite ↗

Also known as: Cyclerion Therapeutics | Cyclerion Therapeutics, Inc | Cyclerion Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 10, 2021

Timeline

2010s

Jan 1, 2018
Cyclerion Therapeutics, Inc.— Founded

Drugs by trial phase (5 distinct, 8 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

MELAS Syndrome

Recent trials (13)

NCT04972227Lead sponsorPhase 1Sep 10, 2021
NCT04972227Study directorPhase 1Sep 10, 2021
NCT04798989Lead sponsorPhase 2Jun 1, 2021
NCT04798989Study directorPhase 2Jun 1, 2021
NCT04475549Study directorPhase 2Nov 13, 2020
NCT04475549Lead sponsorPhase 2Nov 13, 2020
NCT04240158Lead sponsorPhase 1Jan 6, 2020
NCT04240158Study directorPhase 1Jan 6, 2020
NCT03892499Study directorPhase 1May 3, 2019
NCT03892499Lead sponsorPhase 1May 3, 2019
NCT03818295Lead sponsorPhase 1Mar 1, 2019
NCT03856827Lead sponsorPhase 1Jan 17, 2019
NCT03795519Lead sponsorPhase 1Jan 17, 2019

Details

Founded: Cambridge, MA, US Jan 1, 2018
Last known activity: Sep 10, 2021